Exagen Inc. XGN Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$20.17M-30.0% | -$19.95M-32.0% | -$19.04M-12.5% | -$16.98M+1.9% | -$15.51M+19.9% | ||
| $2.4M+47.3% | $2.16M+22.4% | $1.89M-9.9% | $1.51M-45.4% | $1.63M-48.9% | ||
| —— | —— | —— | -$15.73M— | -$15.27M— | ||
| $756K+39.5% | $641K+24.5% | $743K+56.4% | $615K+86.4% | $542K+4.6% | ||
| -$747K-39.4% | -$626K-21.6% | -$737K-62.7% | -$609K-97.7% | -$536K-8.5% | ||
| $653K+1,455% | $592K— | $427K— | $265K— | $42K— | ||
| $24.82M+4,059% | $24.82M+3,843% | $24.6M+3,789% | $21.53M+3,392% | -$627K+94.1% | ||
| —— | —— | $13.62M— | $5.55M— | -$16.07M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Exagen Inc. generate?
- Exagen Inc. (XGN) generated -$27.0M in operating cash flow over the trailing twelve months.
- What is Exagen Inc.'s free cash flow?
- After $756.0K of capital expenditures, Exagen Inc.'s free cash flow was -$27.6M over the trailing twelve months, down 96.9% year over year.
- Where does Exagen Inc.'s cash flow data come from?
- Every line is extracted from Exagen Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
